Our analysis showed that SREBP2 mRNA expression was associated with mean survival of diffuse glioma patients, and that expression of genes involved in SREBP2-orchestrated cholesterol metabolism processes, including de novo synthesis, uptakes, conversion, and efflux, was all suppressed in GBM cells from the database samples. This evidence concerns the gene SREBF2 and glioblastoma.